Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,770 | -6,680 | -8,380 | -4,920 | -8,970 |
| Depreciation Amortization | 3,340 | 2,650 | 1,940 | 1,020 | 4,690 |
| Other Working Capital | -4,390 | -2,400 | 2,330 | -870 | -3,320 |
| Other Operating Activity | -500 | -170 | -660 | 440 | 2,150 |
| Operating Cash Flow | $-10,320 | $-6,600 | $-4,770 | $-4,330 | $-5,450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,710 | -1,390 | -1,270 | -890 | -3,460 |
| Other Investing Activity | 1,360 | 580 | 3,430 | 4,290 | 9,480 |
| Investing Cash Flow | $-350 | $-810 | $2,160 | $3,400 | $6,020 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 6,140 | 6,000 | 5,470 | -1,830 | -770 |
| Financing Cash Flow | $6,140 | $6,000 | $5,470 | $-1,830 | $-770 |
| Exchange Rate Effect | -190 | -40 | 530 | 400 | -320 |
| Beginning Cash Position | 8,180 | 8,180 | 8,180 | 8,180 | 8,710 |
| End Cash Position | 3,450 | 6,720 | 11,580 | 5,830 | 8,180 |
| Net Cash Flow | $-4,720 | $-1,450 | $3,400 | $-2,350 | $-530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,320 | -6,600 | -4,770 | -4,330 | -5,450 |
| Free Cash Flow | -10,320 | -6,600 | -4,770 | -4,330 | -5,450 |